Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industries

PanFlu is the recipient of the "Monoclonal Antibody Solution of the Year" award in the fourth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough.

"Current seasonal flu vaccines don't always protect optimally, especially for the elderly and other vulnerable groups," said Koenraad Wiedhaup, a founder and CEO of Leyden Labs.

"Mucosal protection with PanFlu has the potential to provide people further control to protect themselves from seasonal flu," said Bryan Vaughn, Managing Director, BioTech Breakthrough.